Effects of "tianqi Pingchan Gradule" on Dyskinesia Behavior and Expression of Signal Transduction Protein in Rats with Parkinson's Disease

吴娜,宋璐,杨新新,魏江磊,刘振国
DOI: https://doi.org/10.16306/j.1008-861x.2013.01.018
2013-01-01
Abstract:Objective:To study the effects of Tianqi Pingchan Graduleon the dyskinesia behavior and the expressions of DARPP-32 and ERK phosphorylations in rats with Parkenson’s disease(PD).Methods:The parkinsonian model was established by injecting 6-OHDA to right medial forebrain bundle(MFB),and the model rats were randomly divided into five groups with five rats in each group.The PD group was treated by intraperitoneal injection with 0.2% vitamin C,the western medicine group was treated by intraperitoneal injection with levodopa methyl ester for 29 days,the Chinese medicine groups(low,medium and high doses) were treated by intraperitoneal injection with levodopa methyl ester plusTianqi Pingchan Graduleintragastrically,and another five rats were served as control group(sham-operation group).The dyskinesia behavior of PD model rats was evaluated,and the expressions of DARPP-32 and ERK phosphorylations were detected by immunohistochemical method.Results:Tianqi Pingchan Gradule can reduce the peak rotation caused by long-time administration of levodopa methyl ester.The immunohistochemical results showed:compared with the PD group,the expression of phosphorylation DARPP-32 significantly decreased in western medicine group,and there was no obvious decrease in Chinese medicine groups(medium and high dose)(P 0.05);compared with the PD group,the expression of phosphorylation ERK1 /2 significantly increased in western medicine group,and there was no obvious increase in Chinese medicine groups(medium and high dose)(P0.05).Conclusion:Tianqi Pingchan Gradulecan decrease the dyskinesia behavior of PD rats,and its mechanisms may have relationship with reversing the phosphorylations of DARPP-32 and ERK1 /2,and regulate the abnormal signal transduction.
What problem does this paper attempt to address?